期刊文献+

1例人工瓣膜置换患者抗凝治疗的药学实践

Practice of Anticoagulant Therapy for a Patient Receiving Heart Valve Replacement Surgery Participated by Clinical Pharmacists
下载PDF
导出
摘要 目的通过1例机械瓣膜置换术后患者的抗凝治疗经过,分析机械瓣膜置换术后抗凝药物、抗凝强度及抗凝过量后的处理,同时纠正不合理用药,促进合理用药。方法临床药师介入1例风湿性二尖瓣关闭不全并发心力衰竭患者行“瓣膜置换术”后的抗凝治疗,协助制定抗凝方案,分析引起抗凝过量的原因并提供处理意见,同时全程监控治疗药物,就不合理用药提出警示。结果患者转归良好,住院及出院随访期间未发生不良事件。结论临床药师的参与有助于精细化管理患者的药物治疗方案,并及时纠正不合理用药,更好的为患者服务。 OBJECTIVE To analyze the anticoagulant drugs,anticoagulant intensity and the management of excessive anticoagulation,and to correct irrational drug use and promote rational drug use by pharmaceutical practice of clinical pharmacists in a patient undergoing mechanical valve replacement.METHODS Clinical pharmacists were involved in the anticoagulant treatment of a patient after heart valve replacement who was diagnosed as rheumatic mitral insufficiency with heart failure.Pharmacists assisted in the formulation of anticoagulant program,analyzed the causes of anticoagulant excess and provided treatment suggestions,and monitored the therapeutic drugs throughout the process to warn against unreasonable use of drugs.RESULTS The patient had a good outcome and no adverse events occurred during hospitalization and discharge follow-up.CONCLUSION The participation of clinical pharmacists is helpful for fine management of drug therapy,timely correction of irrational drug use,and better service for patients.
作者 苏会源 刘声野 李波霞 受国徽 SU Hui-yuan;LIU Sheng-ye;LI Bo-xia;SHOU GUO-hui(People’s Hospital of Linxia Hui Autonomous Prefecture Linxia 731100,China;The First Hospital of Lanzhou University,Lanzhou 730000,China;Tianshui City Hospital of Combined Traditional Chinese and Western Medicine,Tianshui 741020,China)
出处 《海峡药学》 2024年第7期66-69,共4页 Strait Pharmaceutical Journal
基金 甘肃省自然科学基金(21JR7RA380)。
关键词 瓣膜置换术 新型口服抗凝药 维生素K拮抗剂 低强度抗凝 抗凝过量处理 Valve replacement New oral anticoagulants Vitamin K antagonists Low-intensity anticoagulation Anticoagulation overtreatment
  • 相关文献

参考文献5

二级参考文献49

  • 1唐白云,童萃文,张希,王治平,陈光献,熊迈,姚尖平,罗红鹤,黄素珍,孙培吾.机械瓣膜替换术后抗凝治疗的国际标准化比值监测[J].中山大学学报(医学科学版),2004,25(6):568-572. 被引量:7
  • 2盛琴慧,丁燕生,杨俊娟,任自文.华法林抗凝治疗的临床现状分析[J].中国综合临床,2005,21(12):1068-1069. 被引量:4
  • 3胡大一,张鹤萍,孙艺红,姜立清.华法林与阿司匹林预防非瓣膜性心房颤动患者血栓栓塞的随机对照研究[J].中华心血管病杂志,2006,34(4):295-298. 被引量:162
  • 4王宗社,舒端朝,魏涛,王小军,王淑霞.机械瓣置换术后华法林抗凝治疗的临床研究[J].中国心血管病研究,2007,5(2):124-126. 被引量:13
  • 5Acar J,Iung B,Boissel JP,et al.AREVA;multicenter ran-domized comparison of low-dose versus standard-dose anticoag-ulation in patients with mechanical prosthetic heart valves[J].Circulation,1996,94(9):2107.
  • 6Aagaard J,Tingkff J,Hansen CN,et al.Twelve years clini-cal experience with the Carbomedics prosthetic heart valve[J].J Heart Valve Dis,2001,310(2):177.
  • 7Meurin P,Tabet JY,Weber H,et al.Low-molecular-weight heparin as a bridging anticoagulant early after mechanical heart valve replacement[J].Circulation,2006,113(4):564.
  • 8Baglin TP,Keeling DM,Watson HG.Guidelines on oral an-ticoagulation(warfarin):third edition-2005update[J].Br J Haematol,2005,132(3):277.
  • 9Gan GG,Teh A,Goh KY,et al.Racial background is a de-terminant factor in the maintenance dosage of warfarin[J].Int J Hematol,2003,78(1):84.
  • 10Ouirke W,Cahill M,Perera K,et al.Warfarin prevalence,indications for use and haemorrhagic events[J].Ir Med J,2007,100(3):402.

共引文献1028

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部